Alumis Inc.

NASDAQ: ALMS
Share price (4/25/25): $4.28
Market cap (4/25/25): $233 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024 – amended

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Prospectus supplement

Details of business combination or exchange offer

Business combination disclosure

Business combination disclosure

Business combination disclosure

Ownership Filter

Hardiman Roy C.

Richardson Derrick

Schroer John R.

News Filter

Alumis and ACELYRIN Announce Amended Merger Agreement

Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan

Reports Year End 2024 Financial Results and Highlights Recent Achievements

Transform Therapies. Reimagine Lives. March 2025 Corporate Presentation Supplemental Materials

Late-Breaking ESK-001 Phase 2 OLE Data Presented at 2025 AAD Annual Meeting Demonstrate Robust Clinical Responses Over 52-Weeks in Psoriasis

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Notice of effectiveness

Letter from the SEC

SEC STAFF LETTER

Notice of effectiveness